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Human tyrosylprotein sulfotransferases catalyze the transfer of a sulfuryl moiety from the
universal sulfate donor PAPS to the hydroxyl substituent of tyrosine residues in proteins and
peptides to yield tyrosine sulfated products and PAP. Tyrosine sulfation occurs in the
trans-Golgi network, affecting an estimated 1% of the tyrosine residues in all secreted and
membrane-bound proteins in higher order eukaryotes. In this study, an effective LC-MS-based
TPST kinetics assay was developed and utilized to measure the kinetic properties of human
TPST-2 and investigate its catalytic mechanism when G protein-coupled CC-chemokine
receptor 8 (CCR8) peptides were used as acceptor substrates. Through initial rate kinetics,
product inhibition studies, and radioactive-labeling experiments, our data strongly suggest a
two-site ping-pong model for TPST-2 action. In this mechanistic model, the enzyme allows
independent binding of substrates to two distinct sites, and involves the formation of a
sulfated enzyme covalent intermediate. Some insights on the important amino acid residues at
the catalytic site of TPST-2 and its covalent intermediate are also presented. To our knowledge, this
is the first detailed study of the reaction kinetics and mechanism reported for human TPST-2 or any
other Golgi-resident sulfotransferase. (J Am Soc Mass Spectrom 2010, 21, 1633–1642) © 2010
Published by Elsevier Inc. on behalf of American Society for Mass SpectrometrySulfotransferases (ST) catalyze the transfer of asulfuryl group (SO3) from a donor molecule, usually3=-phosphoadenosine 5=-phosphosulfate (PAPS), to
a variety of amine- and hydroxyl-containing substrates,
including proteins [1, 2], carbohydrates [3, 4] and low
molecular weight metabolites [5, 6], as nucleophiles.
There are two classes of STs: cytosolic STs, which are
involved in detoxification, hormone regulation, and
drug metabolism, and membrane-associated STs, which
were identified recently as central players in a number
of molecular recognition events and biochemical signal-
ing pathways [7]. Moreover, sulfotransferases play a
significant role in modulating normal and pathophysi-
ologic processes [3, 8].
Because of STs biological importance and medical
relevance, there is an intense interest towards under-
standing the exact functions of these enzymes. Early
studies focused on cytosolic STs structure, substrate
specificity, and kinetic mechanism through crystallo-
Address reprint requests to Dr. J. A. Leary, Department of Molecular and
Cellular Biology, University of California, One Shields Ave., Davis, CA
95616, USA. E-mail: jaleary@ucdavis.edu
© 2010 Published by Elsevier Inc. on behalf of American Society for M
1044-0305/10/$32.00
doi:10.1016/j.jasms.2010.03.037graphic and mutational studies which provided critical
information about the active site residues involved in
substrate binding and ST catalysis [7]. Direct kinetic
analyses were performed as well to investigate the
catalytic mechanism of several cytosolic and bacterial
sulfotransferases. Initial rate studies have described
distinct modes of catalysis for different STs includ-
ing: (1) ordered Bi Bi mechanism was elucidated for
phenol (SULT1A1 and SULT1A3) [9, 10] and flavonol
(SULT201A1) [11] sulfotransferases; (2) random Bi Bi
mechanism for estrogen sulfotransferase (SULT1E1)
[12], retinol dehydratase [13], and Stf0 sulfotransferase
[14]; and, (3) ping pong mechanism was reported for
bacterial arylsulfate (ASST) [15] and NodH sulfotrans-
ferase (NodST) [16, 17].
A strong interest on the molecular enzymology of
membrane-associated STs, such as tyrosylprotein sulfo-
transferases (TPSTs) and carbohydrate STs, evolved
when studies showed that sulfation of cell-surface pro-
teins by these enzymes appear to trigger vital molecular-
recognition and signal-transduction events [2, 3]. For
example, tyrosine sulfation of G protein-coupled chemo-
kine receptors CCR8, CCR5, CCR2, CX3CR1, CXCR4, and
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chemokines [1, 18–23]. Interaction between the recep-
tors and their ligands direct the migration of leukocytes
for homeostatic purposes and in response to pro-
inflammatory signals. Despite this biological signifi-
cance, structural and mechanistic information on these
Golgi-resident sulfotransferases are limited [24–27].
Two tyrosylprotein sulfotransferase isozymes have
been identified, TPST-1 and TPST-2 (EC 2.8.2.20). These
STs catalyze sulfuryl group transfer from PAPS to
tyrosine residues within highly acidic motifs in proteins
and peptides [28–30]. Human TPST-1 and -2 are 50
kDa type-II transmembrane glycoproteins located in the
trans-Golgi network. They share 65% sequence ho-
mology and both are composed of a short N-terminal
cytoplasmic domain, a single 17-residue transmem-
brane domain, and a luminal catalytic domain [31]. Both
TPST-1 and -2 are broadly co-expressed in mammalian
cells [28–30, 32, 33]. It was estimated that up to 1% of all
tyrosine residues in the eukaryotic proteome are sul-
fated making it a very widespread post-translational
modification [32–34].
In-depth characterization of TPST isozymes has been
hampered by two factors; the lack of homogenous
enzyme preparations, and a fast and accurate assay for
quantitative kinetics analysis. Most previous reports on
kinetic properties of TPST have employed crude en-
zymes [35–37] or highly enriched TPST from adrenal
medulla [38] without knowing if both isozymes are
present or not. In most of these studies, radioactive
labeling assays using [35S]PAPS were used to monitor
the formation of sulfated products. Accuracy of these
methods can vary greatly, thus compromising the cor-
rectness of the kinetic parameters reported. More im-
portantly, these methodologies only allow the monitor-
ing and quantification of total sulfation of tyrosine
residues in products and could not differentiate be-
tween mono-, di-, and trisulfated products, which are
present in many natural substrates such as CCR8 and
CCR5. Recently, we developed a new LC-MS-based
enzyme assay to monitor the formation of the mono-
and disulfated products of CCR8 using reverse-phase
(RP) HPLC coupled directly to a linear ion trap mass
spectrometer equipped with an electrospray ionization
source (ESI-MS) [39]. Using this method, the apparent
kinetic parameters were obtained for purified recombi-
nant human TPST-1 and TPST-2.
In this study, we present a detailed mechanistic char-
acterization of recombinant human TPST-2-catalyzed sul-
furyl group transfer from PAPS to two different accep-
tor peptides modeled on the N-terminus of human
CCR8 (Figure 1) using our LC-MS-based assay. We
chose to work with TPST-2 since our previous research
showed that it’s turnover number is ten times higher
than TPST-1, although studies are ongoing to gain
mechanistic insight into TPST-1 as well [39]. The cata-
lytic mechanism of TPST-2 was determined to be a
rapid equilibrium random two-site ping pong mecha-
nism by initial rate kinetics and product inhibitionstudies, and confirmed by detection of a sulfated-
enzyme covalent intermediate. Some insights on the
TPST-2 active site and covalent intermediate are also
presented based on chemical modification experi-
ments and multiple sequence alignment with differ-
ent STs. These are the first data reported on the
reaction mechanism of human TPST-2, a Golgi-resident
sulfotransferase.
Experimental
Materials
Human CCR8 peptides (amino acids 12–20), VTDYYYPDI
(nonCCR8), VTDsYYYPDI (sY15CCR8), VTDsYYsYPDI
(sY15sY17CCR8), and the sY15CCR8 I20G variant
(VTDsYYYPDG) were synthesized and HPLC-purified
to 95% purity by Quality Controlled Biochemicals
(QCB, Hopkinton, MA, USA). PAPS (95% purity) was
prepared in-house as described previously [40]. All
reagents used were of analytical grade and were pur-
chased from Sigma-Aldrich (St. Louis, MO, USA), while
HPLC-grade solvents were from Fisher Scientific (Fair-
born, NJ, USA). Peptide concentrations were determined
using UV-Vis spectroscopy at 280 nm with 280  3840
cm1 M1 at pH 7.0 for nonCCR8, and at 260 nm260
283 cm1 M1 for sY15CCR8, sY15sY17CCR8, and the
sY15CCR8 I20G variant.
TPST-2 Assay
A recombinant epitope-tagged soluble form of human
TPST-2 was used in all studies. In the recombinant
enzyme, the native N-terminal 24 amino acids of
TPST-2, including the cytoplasmic and transmembrane
domain were replaced with the transferrin signal pep-
tide (MRLAVGALLVCAVLGLCLA) followed by the
12-residue epitope for the Ca2-dependent mAb HPC4
[28]. Thus, the N-terminus of the recombinant soluble
enzyme is NH2-EDQVDPRLIDGKDPG
25Q (HPC4
epitope is underlined) after signal peptide cleavage. The
recombinant soluble enzyme was purified from perma-
Figure 1. Tyrosine sulfation of CCR8 peptides by TPST-2. Reac-
tion 1 shows the sulfation of nonsulfated CCR8 to monosulfated
product sY15CCR8 while reaction 2 shows the formation of the
disulfated product sY15sY17CCR8 from monosulfated sY15CCR8.nently-transfected CHO-K1 cells by HPC4 affinity chro-
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disulfide-linked dimer and was assayed as previously
reported [39]. Briefly, TPST-2 was assayed in the for-
ward direction by monitoring the formation of the
sulfated products of the two reactions in Figure 1. One
unit (U) is equal to 1 mol product formed per min.
All reaction mixtures contained 20 mM 3-(N-
morpholino) propanesulfonic acid (MOPS), pH 7.5, 100
mM NaCl, and 10% (wt/vol) glycerol in addition to
substrates, inhibitors, and enzymes, in a final volume of
60 L, and were incubated at 30 °C. Reaction time
optimization for Reaction 2 was performed on 1 M
TPST-2 allowing it to proceed from 3 to 110 min
(Supporting Information 1, which can be found in the
electronic version of this article). Optimal reaction time
with linear response of substrate to product conversion
can be reached when Tq is 20 min (Supporting Infor-
mation 1, insert). A similar optimization experiment for
Reaction 1 was performed and published previously
[39]. All reactions were initiated by the addition of
250–750 nM TPST-2 with a total reaction time varied
from 6 to 20 min and were quenched by the addition of
methanol containing 0.5 M final concentration of the
internal standard (IS), VTDsYYYPDG peptide. This
peptide was chosen as the IS since its molecular mass
and ionization efficiency are very similar to the sulfated
products. Under these conditions, all initial velocity
reactions converted less than 10% of the substrates to
products. In most cases, no more than 5% of substrates
were utilized at the end of the reaction. The product
concentrations were very low therefore product inhibi-
tions were negligible. Before sample introduction into
the LC-MS system, quenched reaction mixtures were
diluted with 20 mM ammonium acetate.
Mass Spectrometry
All mass spectra were acquired on an LTQ linear ion
trap mass spectrometer with a Surveyor HPLC system
coupled to an electrospray ionization source (Thermo
Electron, San Jose, CA, USA). Analytical samples were
separated on a Zorbax Eclipse XDB C8 column (3 m,
80 Å) (Agilent Technologies, Palo Alto, CA, USA) using
a gradient from 2 to 100% eluent B over 30 min at a flow
rate of 75 L/min (eluent A, 20 mM ammonium acetate,
pH 7, in water; eluent B, 20 mM ammonium acetate, pH
7, in 80% acetonitrile). The first 5 min of the analytical
run was directed to waste for desalting purposes and
then redirected to the ion source for MS analysis in the
negative ionization mode. The ion transfer capillary
was heated to 225 °C and the spray voltage was held at
a potential of 3.5 kV. Selected ion monitoring (SIM)
mode was used for quantification, focusing on the total
ion count (TIC) peak areas representing the IS and the
product. Twenty scans for each of the IS and product
chromatographic peaks were averaged and used to
determine their peak intensity ratio (IP/IIS). This ratio is
directly related to product concentration and was usedto determine the unknown concentrations of subse-
quent products formed.
Quantification
For quantification purposes, both the singly-charged
and the doubly-charged species of each peptide were
monitored in SIM and their intensities, I, were summed
to obtain their respective total intensities, ITOT.
ITOT (peptide) I(singly-charged) I(doubly-charged) (1)
A seven-point calibration curve was used for product
quantification where the samples contained varying
concentrations of the monitored product while keeping
the IS concentration constant. Each of the calibration
standards was analyzed in SIM mode to obtain the ratio
of the intensity of the product (IP) and the IS (IIS), IP/IIS.
Calibration curves were generated from IP/IIS versus
[product]/[IS] plots and the slope of the line, m, was
calculated such that [P] from each subsequent reaction
could be determined from eq 2.
[Product] (IP ⁄ IIS) [IS] ⁄ m (2)
Once [P] is calculated, it can be used to calculate the
velocity of the reaction, , at any given substrate con-
centration and quench time, Tq, of the reaction by using
eq 3:
 [P] ⁄ Tq (3)
Data Analysis
Initial velocity data were first analyzed graphi-
cally using primary plots of 1/ versus 1/[S] using
DeltaGraph Pro 4.05c, where [S] equals substrate con-
centration. Slopes and intercepts obtained from the
primary plots were then graphed as secondary plots
against the reciprocal concentrations of the fixed sub-
strates and product inhibitor concentrations. The form
of the overall rate equation was determined by exami-
nation of the results of graphical analysis. Final values
for kinetic constants shown in Table 1 were obtained by
fitting all data used in primary plots to the overall rate
equation. Data were then each fitted for: (1) the ping-
pong initial velocity pattern to eq 4, (2) competitive
inhibition to eq 5, and (3) noncompetitive inhibition to
eq 6 [41].
Vmax [A] [B] ⁄ (KmB[A]KmA[B] [A] [B]) (4)
Vmax [A] ⁄ KmA (1 [I] ⁄KI) [A] (5)
Vmax [B] ⁄ KmB (1 [I] ⁄KI) [B] (1 [I] ⁄KI) (6)
In these equations,  represents the measured velocity,
Vmax is the maximum velocity, A and B are substrates,
ations
1636 DANAN ET AL. J Am Soc Mass Spectrom 2010, 21, 1633–1642KmA and KmB, are the Michaelis Menten constants for A
and B, and KI is the inhibition constant of product, P.
Although the kinetic results are presented in graphs
of double reciprocal form, all data analyses were per-
formed on a best fit to the hyperbolic form of rate
equations using the iterative minimum X2 nonlinear
regression method of Leatherbarrow [42] to avoid er-
rors inherent to linear plot estimations. Kinetic con-
stants derived from the best fit results were then
compared to the estimates calculated from the intercept
and slope replots. All kinetic constants are reported as
the mean determined from two to three independent
experiments.
TPST-2 Covalent Intermediate
TPST-2 (0.16 nmol) and 50 M 35S-PAPS (50 M) were
incubated for 6 h at 37 °C in the presence or absence of
recombinant human factor IX (0.4 nmol, BeneFIX;
Wyeth Pharmaceuticals Inc., Philadelphia, PA, USA).
Reactions were performed in 0.1 M NaCl, 20 mM
1,4-piperazinediethanesulfonic acid (PIPES), pH 6.9, 2
mM EDTA in a 100 L final volume. Samples were then
boiled in Laemmli SDS sample buffer and electropho-
resed on 4%–15% Tri-glycine SDS polyacrylamide gels
under non-reducing conditions and proteins stained
with GelCode Blue (Thermo Fisher Scientific, Pitts-
burgh, PA, USA). The gels were dried and subjected to
autoradiography using BioMax MS film (Kodak, Sigma-
Aldrich, St. Louis, MO, USA). The bands were excised,
dissolved in 30% H2O2 (60 °C, 15 h) and counted by
liquid scintillation counting. Based on the counts, it was
estimated that under these conditions 0.026 mol of
sulfate were incorporated per mole of TPST-2.
Chemical Modification of TPST-2
TPST-2 under non-reducing conditions was incubated
with an excess of the respective reagent (DEPC, dieth-
Table 1. Kinetic constants of human TPST-2a at 30°C
Constant Descript
Reaction 1: sulfation of
nonCCR8
Vmax Maximal velocity of sulfation of n
KmA Michaelis constant for nonCCR8
KmB Michaelis constant for PAPS at sa
KI Product inhibition constant for PA
KI’ Product inhibition constant for PA
Reaction 2: sulfation of
sY15CCR8
Vmax Maximal velocity of sulfation of s
KmA Michaelis constant for sY15CCR8
KmB Michaelis constant for PAPS at sa
KI Product inhibition constant for PA
KI’ Product inhibition constant for PA
aThe kinetic constants were determined from appropriate plots and equ
values obtained in two or three independent experiments.ylpyrocarbonate at 10 mM; DTNB, 5=5-dithio-bis(2-nitrobenzoic acid) at 10 mM) for 10 min at pH 7.5, 30 °C.
Both DTNB and DEPC in aqueous condition undergo
hydrolysis which means it is not likely to interfere with
the assay. TPST-2 assays were performed with 375 nM
TPST-2, 500 M nonsulfated CCR8, and 200 M PAPS,
and normalized by comparison with the activity of the
unmodified enzyme as control. Experiments were re-
peated three times and results were averaged.
Multiple Sequence Alignment
To identify conserved regions in TPST-2, 28 identified
and predicted TPST-1 and -2 sequences from different
species were retrieved from NCBI Protein database. All
sequences with at least 40% sequence identity were
analyzed by multiple sequence alignment generated
using ClustalW [43]. The sequences were then further
analyzed by aligning them with protein sequences of
other well-studied sulfotransferases from differ-
ent species: six NodH STs, 10 heparan sulfate 3-O-
sulfotransferases (HS-3-OST), seven heparan sulfate
2-O-sulfotransferases (HS-2-OST), 10 heparan sulfate
6-O-sulfotransferases (HS-6-OST), three sulfotrans-
ferase domains of N-deacetylase/N-sulfotransferase
(HS-N-ST), and four cytosolic STs including EST. The
information gathered was then used to identify and
compare the presence of conserved structural motifs of
ST family in TPSTs. TPST and NodST sequences were also
compared to distinguish if there is a similarity between
TPSTs and the NodST tryptic peptide identified to contain
the sulfuryl group of its covalent intermediate [17].
Results
Initial Velocity Studies
Two-substrate site kinetic studies of the forward reac-
tions were performed using TPST-2 in the absence of
added products for reactions using nonCCR8 and
Mean  SD Units
CR8 7.1  0.2 mU/mg protein
de at saturating PAPS 19.3  1.8 M
ting nonCCR8 peptide 8.7  0.3 M
rsus PAPS 0.74 M
rsus nonCCR8 1.2 M
CR8 1.8  0.1 mU/mg protein
ide at saturating PAPS 3.1  0.2 M
ting nonCCR8 peptide 4.8  0.8 M
rsus PAPS 0.16 M
rsus sY15CCR8 3.8 M
as described in the Experimental section. The data represent the meanion
onC
pepti
tura
P ve
P ve
Y15C
pept
tura
P ve
P vesY15CCR8 as acceptor substrates. Initial velocities were
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and CCR8 peptide substrates. Double reciprocal plots of
1/ versus 1/[S] at various fixed concentrations of the
second substrate in Figure 2 indicate a set of parallel
lines with the same slopes, which is indicative of a
typical ping-pong mechanism.
Figure 2a shows the Lineweaver Burk plot for the
sulfation of CCR8 at Y15 with nonCCR8 as the varied
substrate and PAPS at different fixed concentrations.
Repeated experiments and plots of the same data gave
similar results with no reproducible trend toward cur-
vature or intersection of the lines. Kinetic constants
determined from fits of these primary data to eq 4 are
listed in Table 1. Intercept replots from the primary data
with respect to reciprocal concentrations of the fixed
substrates were also linear as seen in Supporting Infor-
mation 2, A–B. Based on the calculations from the
replots, the estimated Vmax is 6.7 mU/mg protein
(where 1 Unit (U) is equal to 1 mol product formed per
min), Km,PAPS is 8.4 M, and Km,nonCCR8 is 23.9 M,
which are all comparable to the values in Table 1
generated from fitting all data to eq 4. Specificity
constants calculated from Table 1 values are as follows:
kcat/Km for nonCCR8 is 2.7  10
2 M1s1, kcat/Km for
PAPS is 5.9  102 M1s1. The turnover number, kcat,
for sulfation of nonCCR8 is 5.1  103 mol of substrate
converted to product per second.
We similarly performed the kinetic studies with
sY15CCR8, a monosulfated CCR8 peptide, as substrate.
Lineweaver-Burk plots in Figure 2b also show a series
of parallel lines when either sY15CCR8 or PAPS is the
varied substrate, which is fully consistent with a ping-
pong mechanism. Consequently, intercept replots from
the primary data with respect to reciprocal concentra-
tions of the fixed substrates were also linear (Support-
ing Information 2, C–D) and the estimated kinetic
constants (Vmax  1.7 mU/mg protein, Km,PAPS  3.7
M, and Km,sY15CCR8  2.6 M) are all comparable to
the corresponding values in Table 1. Specificity con-
Figure 2. Initial velocity patterns for TPST-2
sY15CCR8. 1/ values were plotted against (a) 1
and (b) 1/[sY15CCR8] at various fixed concentra
can be found in the supporting information secti
three independent experiments.stants calculated from Table 1 values are as follows,
kcat/Km of sY15CCR8 is 4.3  10
2 M1s1, kcat/Km of
PAPS is 2.8 102 M1s1, with a kcat value of 1.3 10
3
s1. As previously reported, the Km value for sY15CCR8
is lower than the nonsulfated CCR8. This indicates that
binding is inherently tighter between sY15CCR8 and
TPST-2, and that prior sulfation is likely to increase the
efficiency of additional subsequent sulfation.
The duplication of pattern between the two reactions
demonstrates that the series of parallel lines observed is
indeed a reflection of a ping-pong catalytic mechanism
for TPST-2 and not an artifact of the specific substrate.
Product Inhibition
To distinguish between a classical one-site and a two-
site ping-pong mechanism for TPST-2 bisubstrate sys-
tem, initial velocities of the enzyme were measured in
the presence of reaction by-product PAP for both Reac-
tion 1, sulfation of nonCCR8 and Reaction 2, sulfation of
sY15CCR8. For Reaction 2, PAP inhibited the reaction
competitively with respect to PAPS as the varied sub-
strate, and noncompetitively with respect to sY15CCR8
as the varied substrate as seen in Figure 3a and b.
Secondary replots of slopes and y-intercepts with re-
spect to PAP concentrations show that all inhibition
patterns are linear functions. The corresponding calcu-
lated KI values for PAP from the replots are close to the
constants determined by fitting the data to eqs 5 and 6
(Table 1): KI,PAP with respect to PAPS is 0.2 M, and
KI,PAP with respect to sY15CCR8 is 3.8 M. These
results were generated from two independent experi-
ments. Similar PAP inhibition patterns were observed
for Reaction 1 (data not shown).
Sulfated TPST-2 Intermediate
To assess if a sulfated TPST-2 intermediate is formed
during the catalytic cycle, three sulfation reactions were
lyzed sulfation of nonCCR8 and sulfation of
CCR8] at various fixed concentrations of PAPS;
of PAPS. Intercept replots of the primary plots
ata represent the mean  standard deviation ofcata
/[non
tions
on. D
prese
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SDS-PAGE and analyzed by autoradiography. Figure 4
shows that when 35S-PAPS and factor IX were com-
bined in the presence (lane 1) or absence of TPST-2 (lane
2), 35S-sulfuryl group transfer to factor IX occurred only
in the presence TPST-2, demonstrating that sulfation
was enzyme dependent. When 35S-PAPS and TPST-2
were combined in the absence of factor IX (lane 3)
incorporation of 35S-sulfate into TPST-2 was observed
demonstrating formation of a 35SO3-TPST-2 covalent in-
termediate. However, the sulfated intermediate was not
observed when factor IX was present (lane 1). These
results indicate that a short-lived sulfated TPST-2 covalent
intermediate is formed before the release of reaction
products.
TPST-2 Chemical Modification
At the reaction pH 7.5, only histidine and cysteine side
Figure 3. Inhibition patterns in the presence of P
7, 10, 15, and 25 M [PAPS] and at different fix
constant at 25 M. Slope replot yields the equation
slope can be used to estimate KI. (b) 1/ versus 1/
and at different fixed concentrations of PAP while
yields KI,y-int  1/Vmax ([I]/KI)  1/Vmax. Data rechains are expected to be neutral and can be sulfury-lated to form the TPST-2 covalent intermediate. Two
chemical modifying agents, DEPC and DTNB, were
incubated with TPST-2 individually before its reaction
with substrates. Supporting information 3 shows that
TPST-2 incubation with DEPC dramatically decreased
TPST-2 activity to 4.4%, suggesting that one or more
histidine residues are critically important for catalysis
[44–46]. Whether a sulfohistidine covalent intermediate
is formed or not is uncertain. In contrast, the activity of
TPST-2 incubated with DTNB was comparable to that of
the control indicating that cysteine residues do not
participate in catalysis.
Multiple Sequence Alignment
Twenty-eight TPST protein sequences (Supporting In-
formation 4) were aligned with forty sequences of
cytosolic, bacterial, and membrane-associated carbohy-
drate sulfotransferases to determine if the conserved 5=
t pH 7.5, 30 °C. (a) 1/ versus 1/[PAPS] plots at 5,
ncentrations of PAP while keeping [sY15CCR8]
pe (Km,B/(Vmax KI)) [I] (Km,B/Vmax) where the
5CCR8] plots at 5,7,10,15 and 25 M [sY15CCR8]
ng [PAPS] constant at 25 M. The intercept replot
nt the mean of two independent experiments.AP a
ed co
KI,slo
[sY1
keepiPSB and 3= PB structural motifs of ST family are present
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acid residues involved in the PAP/PAPS binding do-
main of STs are all highly conserved in TPSTs (Support-
ing Information 4, underlined and bold) [47–52]. These
are amino acid residues Thr51, Thr52, Arg130, and
Ser138 in mouse EST (Thr81, Thr82, Arg183, Ser191 in
human TPST-2). In contrast, Lys48 of mEST corre-
sponds to Arg78 for TPST-2 (Supporting Information 4,
italicized and bold) and Arg18 of NodSTs even when
Lys48 is highly conserved in all other 34 STs analyzed.
Two other mEST amino acids involved in ST catalysis,
Lys106 and His108, were also present in TPSTs (Lys147
and His148) and NodSTs (Lys76 and His79) (Support-
ing Information 4, bold).
Previous work by our group on the two-site ping pong
catalytic mechanism of bacterial NodH ST detected the
presence of a sulfated NodST intermediate by ESI-FT-ICR
mass spectrometry [17]. The NodST tryptic peptide T2–3
(T19GTHYLEELVNEHPNVLSNGELLNTYDTNWPDKE-
R35) was identified to contain a sulfuryl group. Se-
quence alignment between TPSTs, NodSTs and the
sulfurylated tryptic peptide shows clearly five highly
conserved amino acids: Gly20, Thr21, His31, Pro32, and
Gly38 (Supporting Information 5, underlined and bold).
This suggests the possibility that a sulfurylated amino
acid of TPST-2 exists in one of its corresponding amino
acids.
Discussion
The initial velocity double reciprocal plot patterns of
the relationship between pairs of substrates obtained
Figure 4. Detection of sulfated TPST-2 intermediate. 35S-PAPS
and factor IX were combined in the presence (lane 1) or absence of
TPST-2 (lane 2) or 35S-PAPS and TPST-2 were combined in the
absence of factor IX (lane 3) for 6 h at 37 °C as described in
Experimental Procedures. Samples were electrophoresed under
non-reducing conditions and separated proteins stained with
colloidal Coomassie (left panel). The same gel was then dried and
subjected to autoradiography (right panel).for both sulfation of nonCCR8 and sY15CCR8 byTPST-2 showed a series of parallel lines. These results
suggest that the tyrosine sulfation reaction obeys the
rate equation,
1 ⁄  (KmA ⁄Vmax) 1 ⁄ [A] 1 ⁄Vmax (1 (KmB ⁄ [B])) (7)
which is the linear function of the rate equation derived
for a classical one-site ping-pong mechanism. This
mode of catalysis requires the formation of a short-lived
covalent enzyme intermediate which we identified
upon the incubation of TPST-2 with the 35S-labeled
sulfate donor in the absence of the sulfate acceptor
(Figure 4). The TPST-2 covalent intermediate is formed
between the release of the first product, PAP, and
addition of the second substrate, sulfate acceptor
peptide. The initial velocity data and the presence of
35S-sulfate labeled enzyme intermediate clearly pre-
cludes the possibility of a sequential catalytic mecha-
nism for TPST-2; the latter involving binding of both
substrates forming a ternary complex before sulfuryl
group transfer followed by product release in a specific
or random order. This mode of catalysis is reported to
be the more common mechanism for well-studied cyto-
solic and bacterial sulfotransferases [11–14].
While the initial velocity data and the presence of
35S-sulfate labeled enzyme intermediate are consistent
with a classical one-site ping-pong mechanism, the
product inhibition patterns for both sulfation reactions
are not. In the case of a classical ping-pong mechanism
for sulfation of sY15CCR8, the substrate PAPS and
disulfated product sY15sY17CCR8 would bind at a
common site on the free enzyme form, TPST-2, and the
substrate sY15CCR8 peptide and product PAP also
combine at this same common site but with a modified
enzyme form, TPST-2-SO3, the substituted enzyme. As
a consequence, product inhibition patterns between
either PAPS and sY15sY17CCR8 or sY15CCR8 and PAP
will be competitive at saturating concentrations of the
nonvaried substrate. Conversely, product inhibition
patterns obtained between either PAPS and PAP or
sY15sY17CCR8 and sY15CCR8 peptides, which com-
bine with different forms of the enzyme, will be non-
competitive. The results obtained with TPST-2 gave
exactly opposite sets of PAP product inhibition pat-
terns: PAP as a competitive inhibitor of PAPS (Figure
3a), while PAP as a noncompetitive inhibitor of mono-
sulfated sY15CCR8 substrate (Figure 3b). The same PAP
inhibition patterns were observed with respect to PAPS
and nonsulfated CCR8 substrates (plots not shown).
Taken together, these results are consistent with a
two-site ping-pong mechanism where the substrates
PAPS and sY15CCR8 peptide bind independently and
randomly at two different binding sites separated phys-
ically on TPST-2 as opposed to the classical one-site
model [41, 53, 54]. One site binds the peptides, and the
other site binds to the adenosine coenzyme where
sulfation and desulfation occurs at both sites. It is
assumed that all substrates and products bind and
dissociate independently in a rapid equilibrium ran-
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residue can combine at site one before or after PAPS
binds at site two and the binding of one ligand has no
effect on the binding of the other. Similarly, the pres-
ence of a substrate at one site does not influence the rate
of sulfate transfer at the other site. Given that a sulfated
TPST-2 intermediate is identified, the amino acid resi-
due carrying the sulfuryl group is likely flexible enough
to migrate between the two binding sites during the
execution of its function as a sulfuryl-transferring agent.
Therefore, as adapted from the two-site ping-pong
model of transcarboxylase reported by Northrop [53],
the forward reaction of TPST-2 tyrosine sulfation of
nonsulfated CCR8 is summarized as follows: PAPS
binds to its binding site and the sulfuryl group is
transferred to the side-chain of an amino acid in TPST-2.
Binding of the nonsulfated CCR8 and possible dissoci-
ation of PAP occurs randomly and independently. The
flexible sulfated amino acid residue then migrates ad-
jacent to the binding site of nonCCR8 and a second
transfer reaction occurs to form the monosulfated CCR8
product. Finally, the sY15CCR8 product dissociates
from the enzyme surface.
Through radioactive labeling experiments, we were
able to establish the presence of a sulfated TPST-2
intermediate. A sulfated enzyme intermediate was re-
ported previously in a bacterial sulfotransferase NodST,
a two-site ping-pong enzyme, through in-solution di-
gestion experiments and ESI/FT-ICR MS analysis [16,
17]. The sulfuryl moiety was identified to be present
in the tryptic peptide T2–3 (a.a. 19–53) of the NodST
intermediate. Multiple sequence alignment of six Nod-
STs and the T2–3 peptide together with twenty-eight
TPSTs shows five highly conserved amino acids with
Thr81 and His91 of human TPST-2 as possible candi-
dates to be the sulfuryl-carrying nucleophilic amino
acid (Supporting Information 5).
Earlier crystal structure studies on mouse EST
showed similarities between kinases and sulfotrans-
ferases. In some phosphotransferase reactions, the
phosphate group is transferred to a histidine residue to
form a phosphohistidine intermediate before product
formation [55]. Hence, it was proposed by Kakuta and
coworkers that a histidine residue present in the cata-
lytic site of STs may become sulfurylated to form a
sulfohistidine intermediate before the sulfurylated
product [47]. This is an alternative to the formation of a
ternary complex identified to be present in sequential
mechanism of several STs. We suggest that His91 is the
possible sulfuryl moiety carrier in the TPST-2 interme-
diate with the conserved His148 as the catalytic base
necessary to deprotonate the tyrosine-containing pep-
tide substrate. His91 resides in a highly conserved
region of TPSTs right next to the 5=PSB loop. This agrees
with the possibility of His91 carrying the sulfuryl group
and migrate between PAPS and peptide/protein bind-
ing sites. Supporting Information 6 shows a possible
reaction mechanism of TPST for the substrates PAPS
and tyrosine-containing protein. The proposed mecha-nism was recently reported by Malojcic and coworkers
on aryl sulfotransferase (ASST), another ping-pong ST,
from uropathogenic E. coli [45]. They proposed that
upon the sulfation of His436 of ASST, the sulfuryl
moiety of the sulfohistidine intermediate is stabilized
by an extensive network of hydrogen bonding to the
side chains of highly conserved two additional His, one
each of Arg, Asn, and the N-backbone of Thr. This
additional essential role of possible His residues in the
catalytic site of TPSTs was further supported by the
inactivation of TPST-2 through treatment with DEPC, a
reagent that specifically modifies His side chains. Se-
quence alignment of 28 TPST homologs revealed more
histidine residues to be invariant: His190, His244,
His266, and His267. Two or more of these His residues
may be involved in the hydrogen bonding network
stabilizing the TPST sulfohistidine intermediate. Inter-
estingly, it was reported that a mutation in the Tpst2
gene is responsible for an autosomal recessive form of
primary hypothyroidism in the growth-retarded grt/grt
mouse [56]. The mutation (C798G) results in a H266Q
substitution in TPST-2. In this report the authors
showed that wild type TPST-2, but not wild type
TPST-1 or the H266Q TPST-2 mutant, could sulfate a
peptide modeled on a tyrosine sulfation site in the
thyroid-stimulating hormone receptor (TSH-R) in vitro,
suggesting that TPST-2, but not TPST-1, can efficiently
sulfate TSH-R in vivo.
Because of indirect evidence showing the possible
formation of a TPST-2 sulfohistidine intermediate, we
performed in-solution digestion experiments on TPST-2
incubated with PAPS followed by MS analysis. TPST-2
with and without PAPS were digested with trypsin,
chymotrypsin and/or glu-C endoproteinase. Three dif-
ferent mass spectrometers were used for analysis:
Bruker ESI-FT-ICR MS in negative ionization mode,
Thermo Electron LTQ-FT-ICR equipped with a nano-
Acquitty UPLC system in positive mode, and LTQ-
Orbitrap directly coupled to a Surveyor HPLC system
in positive mode. Both hybrid instruments were pro-
grammed to perform MS3 experiments with neutral
loss scan event for the loss of a sulfuryl group. All MS
analyses had mass accuracy  10 ppm with sequence
coverages between 63% and 77%. All His containing
peptides were identified to be present. Unfortunately,
none of the experiments showed proof of a sulfuryl-
carrying amino acid. It is likely due to a very low
abundance intermediate and perhaps one that is quite
unstable. As noted in the Experimental section, for
every mole of TPST-2, only 0.026 mol is sulfated. New
methodology will be required to enrich for the sulfated
intermediate; unfortunately, we do not currently have
such a method in place but one is now being planned.
Kinetic properties of TPST-2 sulfation reactions pre-
sented in Table 1 are consistent with our previous
research which provided the apparent kinetic constants
of TPST-2, TPST-1 and its mixture [39]. As expected, the
Km value of nonsulfated CCR8 peptide is at least five
times higher than the monosulfated peptide counter-
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compared to nonCCR8. However, the lower turnover
number of the disulfation reaction indicates that TPST-2
catalyzes the monosulfation reaction four times more
rapidly from substrate to product once the active sites
are filled. To resolve this dichotomy and any effects of
[S] with respect to Km in the reactions, kcat/Km values
are reported and indicate that sY15CCR8 is the more
suitable substrate than nonCCR8 for TPST-2. Compar-
ing the specificity constants of the respective substrates
of the two sulfation reactions, PAPS is the preferred
substrate over nonCCR8, while sY15CCR8 peptide be-
comes preferred than PAPS. These comparisons indi-
cate that there are important interactions between the
negative charges on the sulfate moiety of the sulfated
peptide and the active sites of TPST-2.
TPST-2 specificity constants reported are relatively
low compared to other values for sulfotransferases. It
can be attributed to the fact that we used artificial
substrates instead of the intact membrane-bound CC
chemokine receptor 8 which is the true substrate in
vivo. Much lower values for similar artificial substrates
were published previously by another group which
showed at least 10,000-fold lower specificity constants
[37]. Another possible reason can be ascribed to the less
conserved Lys48 residue of mEST in TPST-2. Interest-
ingly, Lys48 is substituted by Arg78 at the 5=PSB motif
of TPST-2. Arg is a more basic amino acid than Lys,
hence the corresponding conjugate acid of Arg is less
acidic than Lys. Therefore, Arg exhibits weaker hydro-
gen bonding interactions with the bridging oxygen
between the 5=phosphate and sulfate groups of PAPS.
This can slow down bond breaking between the two
groups for the rest of the reaction to proceed, therefore
affecting the kcat of the reaction. Furthermore, in a
previously published study on mEST, a K48R mutation
caused the kcat of the enzyme to drop at least 4-fold
compared to wild type without changing the Km of the
substrates [49].
In conclusion, initial rate kinetic analyses in the
absence and presence of product PAP, and detection of
a sulfated TPST-2 covalent intermediate via [35S] radio-
active labeling experiment were used to elucidate the
catalytic mechanism of recombinant human TPST-2.
Multiple sequence alignment of 68 sulfotransferases,
including 28 TPSTs, together with chemical modifi-
cation experiments, provided some insights on the
location of the sulfuryl-carrying amino acid in the
TPST-2 covalent intermediate. However, a more di-
rect validation of the presence of a sulfohistidine
intermediate will be required for future studies.
Future studies are also necessary to elucidate the
potential roles of other specific TPST-2 residues in the
tyrosine sulfation mechanism.
Our analysis is consistent with a rapid equilibrium
random two-site ping-pong mechanism for TPST-2.
This is the first detailed study of the reaction kinetics
and catalytic mechanism of a Golgi-resident sulfotrans-
ferase. Our research on the enzymatic properties andmode of catalysis of TPST-2 provides a platform for
understanding the roles of membrane-associated STs in
humans, particularly in tyrosine sulfation of chemokine
receptors, and will aid in discovering potential drug
inhibitors to this emerging novel class of therapeutic
agents [8].
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